A Study on the Preference of Risperidone Dosage Forms
NCT06657430 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2024-10-24
Summary
This study aimed to understand patients' needs and preferences for antipsychotic dosage forms.
Conditions
- Schizophrenia
- Bipolar Affective Disorder
- Autism Spectrum Disorder
- Conduct Disorder
- Mental Retardation
Sponsors & Collaborators
-
Shanghai Mental Health Center
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-09-19
- Primary Completion
- 2025-02-28
- Completion
- 2025-02-28
Countries
- China
Study Locations
More Related Trials
-
Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone
NCT00563017 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness of Tropisetron Plus Risperidone for Improving Cognitive and Perceptual Disturbances in Schizophrenia
NCT00435370 ·Status: COMPLETED ·Phase: PHASE3
-
An Observational Study on Atypical Antipsychotics Long-term Treatment Patients With Schizophrenia
NCT02640911 ·Status: RECRUITING
-
An Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective Disorders
NCT01855074 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Antipsychotics in Individuals at Clinical High-risk for Psychosis (the SHARP-2 Study)
NCT04010864 ·Status: UNKNOWN
-
Efficacy and Safety of Risperidone Oral Solution Combination Clonazepam Versus Haloperidol Intramuscular (IM) Injection for Treatment of Acute Psychotic Agitation in Schizophrenia
NCT00859872 ·Status: COMPLETED ·Phase: PHASE4
-
EFFECT OF RISPERIDONE vs ARIPIPRAZOLE ON OXIDATIVE STRESS IN PATIENTS WITH AUTISM SPECTRUM DISORDER: A RANDOMIZED CONTROLLED TRIAL
NCT05868720 ·Status: UNKNOWN ·Phase: NA
-
Artemisinin With Risperidone for First-Episode and Drug-Naive Schizophrenia
NCT01391403 ·Status: COMPLETED ·Phase: PHASE3
-
Switching From Oral Antipsychotics to Long-Acting Risperidone in Participants With Schizophrenia
NCT01726335 ·Status: COMPLETED ·Phase: PHASE4
-
An Observational Study to Evaluate Efficacy and Safety of Risperidone Long-Acting Injection for Treatment of Schizophrenia
NCT01894984 ·Status: TERMINATED
-
A Study of Risperidone Monotherapy in Bipolar Anxiety
NCT00167479 ·Status: COMPLETED ·Phase: PHASE4
-
A Long Term Study of Safety for Long Acting Injectable Risperidone in Patients With Schizophrenia or Schizoaffective Disorder.
NCT00558298 ·Status: COMPLETED ·Phase: PHASE3
-
Risperidone Maintenance Treatment in Schizophrenia
NCT00848432 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Efficacy and Safety of Risperidone Injections Given Once a Month to Adults With Schizophrenia or Schizoaffective Disorder
NCT00236353 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Effectiveness and Safety of Long-acting Injectable Risperidone Versus Placebo in the Treatment of Patients With Schizophrenia
NCT00253136 ·Status: COMPLETED ·Phase: PHASE3
-
A Multicenter Study to Evaluate the Effects of Switching to Aripiprazole 12 Weeks on the Sexual Dysfunction From Risperidone or Paliperidone in Patients With Schizophrenia Spectrum Disorders or Bipolar Spectrum Disorders
NCT01742390 ·Status: UNKNOWN ·Phase: PHASE4
-
A Research in Pharmacogenomics and Accurate Medication of Risperidone
NCT03302364 ·Status: UNKNOWN
-
A Study of the Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-manic Effectiveness of Risperidone Compared With Haloperidol
NCT00253162 ·Status: COMPLETED ·Phase: PHASE3
-
Antipsychotic to Treat Psychosis Syndrome
NCT02137616 ·Status: UNKNOWN ·Phase: NA
-
Effective Measurement of Risperidone Treatment Outcome for Persons With Borderline Personality Disorder
NCT00204347 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy Study on Cognitive Functions in Schizophrenic Patients
NCT00761670 ·Status: COMPLETED ·Phase: PHASE4
-
The Relationship Between Risperdal Treatment and Quality of Life in Patients With Alzheimer's Disease and Behavioural and Psychological Symptoms of Dementia (BPSD)
NCT00626613 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety, Tolerability, Pharmacokinetics and Efficacy Study of HS-10380 in Patients With Schizophrenia
NCT05964790 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Comparison of Risperidone With Haloperidol in Patients With Schizophrenia and Schizoaffective Disorder
NCT00253110 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Functional Recovery After Switching From Paliperidone Palmitate Injection to Oral Antipsychotics in Schizophrenia
NCT07075237 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4